Clinical Trial

Characterization of Immune Cells and Their Secreted Cytokines in Endometriosis Patients

Study acronym: EUmetriosis
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The EUmetriosis project aims to address the most important unmet needs of endometriosis sufferers to advance patient care. The objectives cover all main aspects of disease management, including elucidating the pathogenesis, diagnosing the condition promptly and efficiently, facilitating care by implementing self-management strategies, raising awareness and promoting policy changes. The objectives comprise individual yet intersecting pieces of a puzzle which, when positioned correctly, can immensely improve disease perception and understanding to enhance patient care. The project will prioritise the needs and wants of modern-day patients, focused on providing easily accessible and noninvasive therapeutic options. Combining all these elements in a well-coordinated project is pivotal to relieving the heavy burden endometriosis places on European society as a whole.
Trial Details
NCT Number NCT06897436
Lead Sponsor Medical University of Lublin
Collaborators: European Commission
Conditions Endometriosis
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-27